·   Log in

Archive for February 25th, 2010

Nevirapine oral suspension pills by Aurobindo gets tentative approval in US

Thursday, February 25, 2010 20:03

Aurobindo Pharma Limited has received the tentative approval to manufacture and market anti-HIV medicine nevirapine tablets for oral suspension 50mg from the US Food & Drug Administration, the company announced in a press release.

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with: , ,

Kindney transplant drug belatacept by BMS may cause fatal side-effects, say US FDA reviewers

Thursday, February 25, 2010 19:16

Belatacept, an investigational drug to counter organ rejection following transplants could lead to potential side-effects including death despite its obvious advantages in improving kidney function, according to the US Food and Drug Administration.

This was posted under category: Biotech  |  Read Full Story  |  0 Comments

India reports 1366 deaths from H1N1 swine flu infection as on 25th Feb, 2010

Thursday, February 25, 2010 18:39

India has reported 1366 deaths from H1N1 swine flu infection in the country as of 25th February 2010, according to an official communique from the ministry of health and family welfare issued by Press Information Bureau.

This was posted under category: health  |  Read Full Story  |  0 Comments
Tagged with: ,

Sun Pharma to launch generic doceferez (Toxotere) in Europe

Thursday, February 25, 2010 15:51

India's Sun Pharmaceutical is set to launch generic doceferez in European markets soon.

This was posted under category: Industry  |  Read Full Story  |  0 Comments
Tagged with: , ,

Indian pharma market zooms to US 21.83 billion (Rs 1,00,611 cr.) in 2009-10

Thursday, February 25, 2010 14:29

The Indian pharmaceutical industry currently values about  Rs 1,00,611 crore, as the industry sector growth is back in track following revival of the economy, according to the latest Economic Survey 2009-10 report.

This was posted under category: Featured, Industry  |  Read Full Story  |  0 Comments
Tagged with: ,